Marché mondial de l’optogénétique – Tendances et prévisions du secteur jusqu’en 2030

 Analyse et taille du marché de l'optogénétique

Selon la Parkinson's Foundation 2020, environ 1,2 million de personnes aux États-Unis pourraient être atteintes de la maladie de Parkinson d'ici 2030. De plus, selon la Société Alzheimer du Canada 2021, plus de 500 000 Canadiens vivent avec la démence. Ce nombre devrait atteindre 912 000 d'ici 2030. Selon le communiqué de presse de l'Agence de la santé publique du Canada de 2019, neuf personnes âgées reçoivent un diagnostic de démence au Canada toutes les heures. Selon les National Institutes of Health, l'investissement estimé dans les neurosciences en 202 est de 10 353 millions USD en mai 2020, une augmentation significative par rapport aux 10 353 millions USD de 2020. L'investissement croissant dans les neurosciences devrait accroître la demande en optogénétique, une nouvelle méthode d'identification des troubles neurologiques. Ce facteur devrait stimuler la croissance du marché.

Data Bridge Market Research analyse que le marché de l'optogénétique, qui s'élève à 0,31 milliard USD en 2022, devrait atteindre 1,11 milliard USD d'ici 2030, à un TCAC de 17,35 % au cours de la période de prévision 2023 à 2030. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Portée et segmentation du marché de l'optogénétique  

Market Definition

Optogenetics is a scientific methodology that combines genetics and optical technologies. It is mostly used to manage and control the biological processes of neurons and other light-sensitive cells. Individual behaviour and physiology, such as locomotion, learning, memory, navigation, metabolism, respiration, and sensor processing, are better understood with this knowledge. Optogenetics contributes to clinical discoveries by illuminating the neuronal processes involved in a variety of disorders such as drug addiction, obsessive compulsion disorder (OCD), Parkinson's disease, stroke, chronic pain, epilepsy, social dysfunction, anxiety, and depression.

Optogenetics Market Dynamics

Drivers

• Rise in chronic diseases

According to the National Center for Chronic Disease Prevention and Health Promotion (January 2021), four o​​​​​​​ut of every ten adults in the United States have two or more chronic diseases, and six out of every ten adults have one or more chronic diseases. These diseases cost the country's healthcare system USD 3.8 trillion per year, which could significantly impact the industry's development under consideration. Rising government initiatives are the primary drivers of growth in the neurological field. With more investment, more businesses can enter the market and provide innovative solutions to patient needs.

• Increasing patient population

According to the Alzheimer's Impact Movement study from July 2020, more than 5 million Americans have Alzheimer's disease, and an estimated 16 million are looking for unpaid care. Alzheimer's disease will cost the country USD 305 billion in 2020, with Medicare and Medicaid payments accounting for USD 206 billion. More care is required for the growing patient population, increasing the optogenetics demand and accelerating market growth.

• Collaborations and agreements

Partnerships and agreements are another factor driving market growth. For instance, in September 2021, NeuroLux Inc. announced an exclusive partnership with TSE Systems to integrate its wireless technology with TSE Systems' IntelliCage and PhenoMaster platforms, providing optogenetic, pharmacology, telemetry, and other capabilities for cutting-edge behavioural neuroscience research.

Opportunities

• Government Initiatives

The increase in government efforts in the neurological field is one of the primary drivers of market growth. As funding grows, more competitors will be able to enter the market and offer cutting-edge solutions to meet the needs of patients. According to the National Center for Chronic Disease Prevention and Health Promotion (January 2021), six out of every ten adults in the United States have a chronic disease, and four out of every ten adults have two or more chronic diseases. These conditions impose an annual burden of USD 3.8 trillion on the nation's healthcare system, which is expected to significantly impact the market's development.

Restraints/Challenges

• Less efficiency of LED’S

LEDs are generally limited to several hundred megabits per second links, whereas lasers can be 25-50 gigabits per second links when directly modulated. As a result, the low efficiency of optical fibres limits the use of LEDs in some applications.

• Awareness of optogenetics

However, the lack of awareness of optogenetics in developing economies compared to developed economies will pose a challenge to the growth of the optogenetics market.

This optogenetics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the optogenetics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Optogenetics Market

The global COVID-19 pandemic is expected to significantly impact the optogenetics market. SARS-CoV-2 has an 85% prevalence in Alzheimer's patients, according to Shanet Suzan Alex's paper for PUS University in February 2022, and causes cerebral problems in addition to respiratory symptoms. Furthermore, SARS-CoV-2 infiltrated the cognitive centres of COVID-19 patients, resulting in Alzheimer's-like phenotypes in people with no other underlying illnesses and worsening Alzheimer's neuropathology in people who already had Alzheimer's and autism, according to the same source. The COVID-19, which has been linked to neurological illnesses, has increased death rates and had a significant impact on the market.

Recent Development

• In 2020, Gensight Biologics S.A. reported that an independent Data Safety Monitoring Board had completed its second planned safety review of the ongoing PIONEER Phase I/II clinical study of GS030 (DSMB). The company's Retinitis Pigmentosa treatment combines gene therapy and optogenetics (RP). The GS030 product is based on the company's own optogenetics technology platform. The GS030 uses gene therapy to make retinal ganglion cells responsive to light and avoid disease-killed photoreceptors by injecting them with a gene code for a light-sensitive protein via a single intravitreal injection.
• In 2019, RMIT (Royal Melbourne Institute of Technology) University researchers developed a device that can mimic how the brain retains and loses information. They achieved this by drawing inspiration from optogenetics. The usage of optogenetics enables researchers to probe the body's electrical system by manipulating neurons to turn them on or off using light.

Global Optogenetics Market Scope

The optogenetics market is segmented on the basis of light equipment type, actuator, sensor and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Light Equipment Type

• Laser
• Light-emitting Diode (LED)

 Actuator

• Channelrhodopsin
• Halorhodopsin
• Archaerhodopsin

Sensor

• Calcium Aequorin
• Cameleon
• Other
• pH Sensors
• Genetically Modified Calcium Indicators
• Neurotransmitter Release
• Voltage-sensitive Fluorescent Proteins
• Chloride (Clomeleon)

• Membrane-gated (Mermaid)

Application

• Neuroscience
• Behavioral Tracking
• Retinal Disease Treatment
• Others

Optogenetics Market Regional Analysis/Insights

The optogenetics market is analyzed and market size insights and trends are provided by country, light equipment type, actuator, sensor and application as referenced above.

The countries covered in the optogenetics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the optogenetics market due to the development in the application of optogenetic tools, principally in educational and analysis labs.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the growing healthcare sector researches across the region.

La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques et l'analyse des cinq forces de Porter, les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte tout en fournissant une analyse prévisionnelle des données nationales.

Croissance de la base installée des infrastructures de santé et pénétration des nouvelles technologies

Le marché de l'optogénétique vous fournit également une analyse détaillée du marché pour chaque pays, la croissance des dépenses de santé pour les biens d'équipement, la base installée de différents types de produits pour le marché de l'optogénétique, l'impact de la technologie utilisant les courbes de vie et les changements dans les scénarios réglementaires des soins de santé et leur impact sur le marché de l'optogénétique. Les données sont disponibles pour la période historique 2011-2021.

Analyse du paysage concurrentiel et des parts de marché de l'optogénétique

Le paysage concurrentiel du marché de l'optogénétique fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché de l'optogénétique.

Certains des principaux acteurs opérant sur le marché de l'optogénétique sont :

• Elliot Scientific Ltd (Royaume-Uni)
• Shanghai Laser & Optics Century Co. Ltd. (Chine)
• GenSight Biologics (France)
• Danaher (États-Unis)
• Cohorent, Inc. (États-Unis)
• Thorlabs, Inc. (États-Unis)
• Prizmatix (Israël)
• Bruker (États-Unis)
• Scientifica (Royaume-Uni)
• Judges Scientific plc (Royaume-Uni)
• Addgene (États-Unis)
• LE LABORATOIRE JACKSON (USA)
• Noldus Information Technology (Chine)
• Merck KGaA (Allemagne)
• agtc (États-Unis)
• Circuit Therapeutics, Inc. (États-Unis)
• Technologies Laserglow (Canada)
• REGENXBIO Inc. (États-Unis)

SKU-53788